Mark Pinkerton, MD, is an Instructor in Medicine in the Division of Hospital Medicine. He joined the division in 2019 after completing his residency at Washington University in St. Louis. He serves as an attending physician on a variety of services including general hospitalist, medical oncology, bone marrow transplant, emergency department hospitalist, nocturnist, and medicine triage. He works at BJH as well as Barnes-Jewish West County. He serves on the recruitment committee for the division. He enjoys teaching medical students and resident physicians in the clinical setting. Areas of interest include care of the hospitalized patient and antibiotic stewardship.
Education
- BS, Microbiology: University of Alabama, Tuscaloosa, AL (2012)
- Medical Degree: University of Mississippi School of Medicine, University, MS (2016)
- Residency, Internal Medicine: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO (2019)
Clinical Interests
Internal Medicine, Hospital Medicine
Publications
Pinkerton, M and T Dy, Insect Allergy In: The Washington Manual of Allergy, Asthma, and Immunology, 3rd Edition. 2018.
Jenny MJ, Walton WC, Payton SL, Powers JM, Findlay RH, O’Shields B, Diggins K, Pinkerton M, Porter D, Crane DM, Tapley J, Cunningham C., Transcriptomic evaluation of the American oyster, Crassostrea virginica, deployed during the Deepwater Horizon oil spill: Evidence of an active hydrocarbon response pathway. Marine Environmental Research 2016: 120: 166-181
Presentations
Journal Club Presentation: Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. The Lancet 2018.
Pinkerton M, Tapley J, Cunningham C, Jenny M.J. (2012). Identification of several glutathione s-transferase and multixenobiotic resistance transporter genes from the American oyster, Crassostrea virginica. Poster presented at: Society for Integrative and Comparative Biology Annual Meeting; Charleston, SC.
Journal Club Presentation: Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. (iPrEx Trial). NEJM 2010.